本應用程式只適用於參加了「集成遠程監控以優化急性心力衰竭伴隨左心室射血分數降低的藥物劑量調整：可行性研究」研究的心臟病患者。研究由心臟專科醫生及其研究團隊負責。
本計劃的旨在為首發急性心力衰竭患者出院後作動態遠程監護，以改善和優化急性心力衰竭患者的指引導向藥物治療。我們相信是次研究的成果將有助於評估遠程監測用於急性心力衰竭患者的可行性，希望能在未來為患有急性心力衰竭患者提供更多院外支援，亦能在心力衰竭惡化之前更早地進行評估和管理。
所有參與均是自願性質，閣下有權在任何時間決定退出本研究。
為了評估遠程監測用於急性心力衰竭患者的可行性，本研究有機會透過應用程式要求用戶提供一些個人資料例如性別、年齡等。
本應用程式亦會收集遠程監控設備的數據，當中包括：
使用本應用程式，即表示您已同意遵守及受本聲明所約束。上傳的血液動力學和生物學數據將由研究團隊每天審查。用戶有權隨時終止提供個人資料及刪除已紀錄的資料。如有需要可聯絡研究人員。
本應用程式只屬研究性質，以評估遠程監測用於急性心力衰竭患者的可行性。本應用程式提供的醫療及藥物資訊僅供參考，研究參加者需與研究醫生及其團隊定時電話聯絡及覆診以確認治療計劃。香港中文大學及其研究團隊不對因使用本應用程式而引致的任何損失、申索、損害、費用或開支承擔任何法律責任。
研究所收集的所有資料和有關的記錄都會被嚴格保密，不會向第三方共享。若您同意此同意書，即表示您批准大學指定研究人員使用您的資料作研究用途。為保護您的個人資料，您的姓名/身份不會顯示在任何報告、刊物或將來被公開的資料。香港法律規定（特別第486 章《個人資料（私隱）條例》），您享有確保閣下的個人資料保密的權利，例如在本研究中有關收集、監管、保留、管理、控制、使用（包括分析或比較）、轉進或轉出香港、不披露、清除和/ 或以任何方式處理或棄置的權利。如有任何問題，請閣下咨詢個人資料私隱專員或其職員（電話號碼：2827 2827），以瞭解妥善監控或監管閣下的個人資料保護之事宜，以確保閣下完整掌握和瞭解遵守規管個人資料私隱的法律之重要性。
有關本計劃的私隱權政策更新，或如您對私隱權政策有任何問題，請聯絡研究人員。
This application is exclusively for heart disease patients participating in the "Integrated Telemonitoring to Optimize Drug Titration for Acute Heart Failure with Reduced Left Ventricular Ejection Fraction: a feasibility study." This study is conducted by cardiologists and their research team.
The aim of this project is to provide dynamic remote monitoring for patients discharged after their first episode of acute heart failure, to improve and optimize guideline-directed medical therapy for acute heart failure patients. We believe the results of this study will help assess the feasibility of remote monitoring for acute heart failure patients in the future, to provide more out-of-hospital support and enabling earlier assessment and management before heart failure worsens.
All participation is voluntary, and you have the right to withdraw from this study at any time.
To assess the feasibility of remote monitoring for acute heart failure patients, this study may require users to provide some personal information such as gender and age through the application. The application will also collect data from remote monitoring devices, including:
By using this application, you indicate that you have agreed to comply with and be bound by this statement. The uploaded hemodynamic and biological data will be reviewed daily by the research team. Users have the right to terminate the provision of personal data and delete recorded data at any time. If needed, please contact the researchers.
This application is for research purposes only, to assess the feasibility of remote monitoring for acute heart failure patients. The medical and medication information provided by the application is for reference only. Research participants need to regularly contact and visit the research doctors and their team to confirm the treatment plan. The Chinese University of Hong Kong and its research team shall not be liable for any losses, claims, damages, costs, or expenses arising from the use of this application.
All data and related records collected will be kept strictly confidential and will not be shared with third parties. By agreeing to this consent form, you authorize the University’s designated researchers to use your data for research purposes. To protect your personal data, your name/identity will not be displayed in any reports, publications, or future publicly disclosed data. Under Hong Kong law, specifically Chapter 486 of the Personal Data (Privacy) Ordinance, you have the right to ensure the confidentiality of your personal data, including collection, supervision, retention, management, control, use (including analysis or comparison), transmission into or out of Hong Kong, non-disclosure, erasure, and/or disposal in any manner. If you have any questions, please consult the Privacy Commissioner for Personal Data (Telephone number: 2827 2827) to understand how to properly monitor or regulate the protection of your personal data, ensuring that you fully grasp and understand the importance of complying with personal data privacy laws.
For updates to the privacy policy of this project, or if you have any questions about the privacy policy, please contact the researchers.